By: Juan Sebastian Chaves Gil
Recently, there has been a notable increase in interest in medicinal cannabis in Europe, leading to regulatory changes in several...
Zhang, Y.-N., Poon, W., Tavares, A. J., McGilvray, I. D. & Chan, W. C. W. Nanoparticle–liver interactions: cellular uptake and hepatobiliary elimination. J. Control....
CRISPR ended 2023 with a bang.In November, the gene editing tool scored its first clinical approval for treating sickle cell anemia and beta-thalassemia in...
Boehringer Ingelheim is the latest pharma company to turn to AI in the hunt for new treatments and therapies.
The German company announced earlier this...
Dive Brief:
PTC Therapeutics on Friday announced its second round of layoffs this year in an attempt to preserve cash following a regulatory setback for its...
Clinical trials receive a lot of oversight from regulatory agencies, as well as independent committees reviewing different aspects of the trial. Depending on the...
Iveric Bio’s marketing authorisation application (MAA) for avacincaptad pegol (ACP) to treat a leading cause of blindness has been accepted for review by the...
Nearly 50% of the children diagnosed with neuroblastoma are considered high-risk, where the tumor has spread, making surgery no longer a viable treatment option....
